The pharma leader is betting that streamlined services may be a shot in the arm for Americans seeking care with its ...
Pfizer's high initial dividend yield, solid ratings, and promising pipeline make it a potentially undervalued investment. See ...
Nobody can predict the future, but it's not hard to imagine increasing pharmaceutical sales. In 2022, prescription drug ...
in the full CMI. Some medicines may interfere with PFIZER DAUNORUBICIN and affect how it works. A list of these medicines is in Section 3. What if I am taking other medicines? in the full CMI.
Pfizer Inc. named oncology research head Chris Boshoff as the drug company’s chief scientific officer while it works to fend ...
Pfizer will work with Ampersand Biomedicines and Montai Therapeutics to find drugs for obesity and lung cancer, respectively, adding to collaborations it previously formed with other Flagship startups ...
Professor Mukharji’s book examines the interplay of colonialism, scientific practices, and the evolution of healthcare ...
Investor's Business Daily on MSN2d
BridgeBio Catapults After Snagging Approval For Its Rival To Pfizer's Heart DrugBridgeBio Pharma snagged FDA approval for its rival to Pfizer's heart disease treatment, Vyndaqel. BridgeBio stock catapulted ...
13d
Robert F. Kennedy Jr. has promised to "make America healthy again." What does that actually mean? Here's everything he ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback